User login
Join me in supporting GI research
A letter from Dr. Robert S. Sandler, MPH, AGAF, Chair of the AGA Research Foundation
At a time when we are on the brink of major scientific breakthroughs, there is a growing gap in federal funding for research. Without gastroenterology and hepatology research, there would be no discoveries to improve our understanding of the pathogenesis of digestive diseases and to develop new diagnostic and therapeutic approaches.
As a member of the AGA, you understand the physical, emotional, and financial costs of digestive diseases. And you understand the tremendous value of research to advance patient care.
Gifts to the Foundation this past year directly supported 66 bright investigators. Despite this success, close to 300 other innovative and promising research ideas went unfunded. We must continue to foster the careers of talented scientists and protect the GI research pipeline.
A financial contribution to the AGA Research Foundation is the opportunity for you to give back to the field in a lasting way. All contributions to the Foundation go to support the Foundation’s research endowment. Please make your tax-deductible donation of $250, $500, $1,000, or any amount you can give.
Thank you in advance for your support and best wishes for a happy, healthy holiday season and successful New Year.
Three easy ways to give
Online: www.gastro.org/donateonline
Through the mail:
AGA Research Foundation
4930 Del Ray Avenue
Bethesda, MD 20814
By phone: 301-222-4002
All gifts are tax deductible to the fullest extent of U.S. law.
A letter from Dr. Robert S. Sandler, MPH, AGAF, Chair of the AGA Research Foundation
At a time when we are on the brink of major scientific breakthroughs, there is a growing gap in federal funding for research. Without gastroenterology and hepatology research, there would be no discoveries to improve our understanding of the pathogenesis of digestive diseases and to develop new diagnostic and therapeutic approaches.
As a member of the AGA, you understand the physical, emotional, and financial costs of digestive diseases. And you understand the tremendous value of research to advance patient care.
Gifts to the Foundation this past year directly supported 66 bright investigators. Despite this success, close to 300 other innovative and promising research ideas went unfunded. We must continue to foster the careers of talented scientists and protect the GI research pipeline.
A financial contribution to the AGA Research Foundation is the opportunity for you to give back to the field in a lasting way. All contributions to the Foundation go to support the Foundation’s research endowment. Please make your tax-deductible donation of $250, $500, $1,000, or any amount you can give.
Thank you in advance for your support and best wishes for a happy, healthy holiday season and successful New Year.
Three easy ways to give
Online: www.gastro.org/donateonline
Through the mail:
AGA Research Foundation
4930 Del Ray Avenue
Bethesda, MD 20814
By phone: 301-222-4002
All gifts are tax deductible to the fullest extent of U.S. law.
A letter from Dr. Robert S. Sandler, MPH, AGAF, Chair of the AGA Research Foundation
At a time when we are on the brink of major scientific breakthroughs, there is a growing gap in federal funding for research. Without gastroenterology and hepatology research, there would be no discoveries to improve our understanding of the pathogenesis of digestive diseases and to develop new diagnostic and therapeutic approaches.
As a member of the AGA, you understand the physical, emotional, and financial costs of digestive diseases. And you understand the tremendous value of research to advance patient care.
Gifts to the Foundation this past year directly supported 66 bright investigators. Despite this success, close to 300 other innovative and promising research ideas went unfunded. We must continue to foster the careers of talented scientists and protect the GI research pipeline.
A financial contribution to the AGA Research Foundation is the opportunity for you to give back to the field in a lasting way. All contributions to the Foundation go to support the Foundation’s research endowment. Please make your tax-deductible donation of $250, $500, $1,000, or any amount you can give.
Thank you in advance for your support and best wishes for a happy, healthy holiday season and successful New Year.
Three easy ways to give
Online: www.gastro.org/donateonline
Through the mail:
AGA Research Foundation
4930 Del Ray Avenue
Bethesda, MD 20814
By phone: 301-222-4002
All gifts are tax deductible to the fullest extent of U.S. law.
MACRA final rule – 2017 is a transition year
This October, CMS released the final rule implementing the provisions of the Medicare Access and CHIP Reauthorization Act (MACRA). AGA is reviewing the 2,398-page regulation and will release a summary of key provisions impacting gastroenterologists in the coming weeks.
• When do changes take effect? Services provided beginning on Jan. 1, 2017, will directly impact reimbursement provided in 2019, the first year in which the MIPS program and APMs are effective.
• What should I do right now? AGA’s MACRA resource center (www.gastro.org/MACRA) provides customized advice based on your practice situation.
• What’s next? Over the coming weeks and months, we will provide detailed information and resources to help practices prepare for the upcoming policy and delivery changes.
Join AGA for our upcoming MACRA webinar series to hear from experts about how MACRA will affect you and your practice. Stay tuned for more information about dates and time. Keep reading below for an overview of the final rule and how it will affect your practice.
Final rule overview
• MACRA implementation will not be delayed. The first performance period begins Jan. 1, 2017, which CMS describes as a “transition year.” However, the final rule provides additional details on CMS’ plan to allow physicians to pick their pace of participation under MIPS (see below).
• Merit-based Incentive Programs (MIPS). CMS lowered the cost performance category to 0% in the 2017 transition period and gave clinicians three reporting options under MIPS and one under Advanced Alternative Payment Models (APMs).
• Option one: Report to MIPS for a full 90-day period or full year on quality, clinical performance improvement activities (CPIA), and advancing care (EHR), and maximize the chance to qualify for positive payment adjustments.
• Option two: Report less than a year, but for the full 90-day period on one quality measure, more than one CPIA, or more than the required measures in advancing care information to avoid penalties and receive a possible positive update.
• Option three: Report one quality measure, one CPIA, or report measures of advancing care to avoid penalty.
• Option four: Join an Advanced APM (see below).
Bottom line: If you do not report at least some data in 2017, you will be penalized.
This October, CMS released the final rule implementing the provisions of the Medicare Access and CHIP Reauthorization Act (MACRA). AGA is reviewing the 2,398-page regulation and will release a summary of key provisions impacting gastroenterologists in the coming weeks.
• When do changes take effect? Services provided beginning on Jan. 1, 2017, will directly impact reimbursement provided in 2019, the first year in which the MIPS program and APMs are effective.
• What should I do right now? AGA’s MACRA resource center (www.gastro.org/MACRA) provides customized advice based on your practice situation.
• What’s next? Over the coming weeks and months, we will provide detailed information and resources to help practices prepare for the upcoming policy and delivery changes.
Join AGA for our upcoming MACRA webinar series to hear from experts about how MACRA will affect you and your practice. Stay tuned for more information about dates and time. Keep reading below for an overview of the final rule and how it will affect your practice.
Final rule overview
• MACRA implementation will not be delayed. The first performance period begins Jan. 1, 2017, which CMS describes as a “transition year.” However, the final rule provides additional details on CMS’ plan to allow physicians to pick their pace of participation under MIPS (see below).
• Merit-based Incentive Programs (MIPS). CMS lowered the cost performance category to 0% in the 2017 transition period and gave clinicians three reporting options under MIPS and one under Advanced Alternative Payment Models (APMs).
• Option one: Report to MIPS for a full 90-day period or full year on quality, clinical performance improvement activities (CPIA), and advancing care (EHR), and maximize the chance to qualify for positive payment adjustments.
• Option two: Report less than a year, but for the full 90-day period on one quality measure, more than one CPIA, or more than the required measures in advancing care information to avoid penalties and receive a possible positive update.
• Option three: Report one quality measure, one CPIA, or report measures of advancing care to avoid penalty.
• Option four: Join an Advanced APM (see below).
Bottom line: If you do not report at least some data in 2017, you will be penalized.
This October, CMS released the final rule implementing the provisions of the Medicare Access and CHIP Reauthorization Act (MACRA). AGA is reviewing the 2,398-page regulation and will release a summary of key provisions impacting gastroenterologists in the coming weeks.
• When do changes take effect? Services provided beginning on Jan. 1, 2017, will directly impact reimbursement provided in 2019, the first year in which the MIPS program and APMs are effective.
• What should I do right now? AGA’s MACRA resource center (www.gastro.org/MACRA) provides customized advice based on your practice situation.
• What’s next? Over the coming weeks and months, we will provide detailed information and resources to help practices prepare for the upcoming policy and delivery changes.
Join AGA for our upcoming MACRA webinar series to hear from experts about how MACRA will affect you and your practice. Stay tuned for more information about dates and time. Keep reading below for an overview of the final rule and how it will affect your practice.
Final rule overview
• MACRA implementation will not be delayed. The first performance period begins Jan. 1, 2017, which CMS describes as a “transition year.” However, the final rule provides additional details on CMS’ plan to allow physicians to pick their pace of participation under MIPS (see below).
• Merit-based Incentive Programs (MIPS). CMS lowered the cost performance category to 0% in the 2017 transition period and gave clinicians three reporting options under MIPS and one under Advanced Alternative Payment Models (APMs).
• Option one: Report to MIPS for a full 90-day period or full year on quality, clinical performance improvement activities (CPIA), and advancing care (EHR), and maximize the chance to qualify for positive payment adjustments.
• Option two: Report less than a year, but for the full 90-day period on one quality measure, more than one CPIA, or more than the required measures in advancing care information to avoid penalties and receive a possible positive update.
• Option three: Report one quality measure, one CPIA, or report measures of advancing care to avoid penalty.
• Option four: Join an Advanced APM (see below).
Bottom line: If you do not report at least some data in 2017, you will be penalized.
Access AGA guidelines and clinical decision support tools on your mobile device
AGA’s gold-standard guidelines, clinical support tools, podcasts, and videos are now available for download via the AGA Clinical Guidelines App, part of AGA’s App Central (http://www.gastro.org/on-demand/aga-app-central). The AGA Clinical Guidelines App offers a quick snapshot of key recommendations, and allows you to input information in a step-by-step format to help you make the most informed decisions possible.
You can even take notes and bookmark information for future reference and quicker decision making.
Only the highest-quality scientific evidence is used to develop AGA’s guidelines. The app currently offers guidelines on:
• Hepatitis B Reactivation.
• Drug Therapy for Crohn’s.
• Constipation.
• IBS Drug Management.
• Colonoscopy after Polypectomy.
• Pancreatic Cysts.
Download the the AGA Clinical Guidelines App and AGA App Central on the Apple App Store or Google Play.
AGA’s gold-standard guidelines, clinical support tools, podcasts, and videos are now available for download via the AGA Clinical Guidelines App, part of AGA’s App Central (http://www.gastro.org/on-demand/aga-app-central). The AGA Clinical Guidelines App offers a quick snapshot of key recommendations, and allows you to input information in a step-by-step format to help you make the most informed decisions possible.
You can even take notes and bookmark information for future reference and quicker decision making.
Only the highest-quality scientific evidence is used to develop AGA’s guidelines. The app currently offers guidelines on:
• Hepatitis B Reactivation.
• Drug Therapy for Crohn’s.
• Constipation.
• IBS Drug Management.
• Colonoscopy after Polypectomy.
• Pancreatic Cysts.
Download the the AGA Clinical Guidelines App and AGA App Central on the Apple App Store or Google Play.
AGA’s gold-standard guidelines, clinical support tools, podcasts, and videos are now available for download via the AGA Clinical Guidelines App, part of AGA’s App Central (http://www.gastro.org/on-demand/aga-app-central). The AGA Clinical Guidelines App offers a quick snapshot of key recommendations, and allows you to input information in a step-by-step format to help you make the most informed decisions possible.
You can even take notes and bookmark information for future reference and quicker decision making.
Only the highest-quality scientific evidence is used to develop AGA’s guidelines. The app currently offers guidelines on:
• Hepatitis B Reactivation.
• Drug Therapy for Crohn’s.
• Constipation.
• IBS Drug Management.
• Colonoscopy after Polypectomy.
• Pancreatic Cysts.
Download the the AGA Clinical Guidelines App and AGA App Central on the Apple App Store or Google Play.
November is National Diabetes Month; SVS Offers Information
November, National Diabetes Month, is a great opportunity to draw more attention to the illness for the public, primary care physicians and patients of all ages.
To help out, we have developed:
- A web page of diabetes and vascular disease resources that we hope you will share with patients and colleagues.
- An easy-to-understand infographic that can be printed and posted around the office or in exam rooms.
- The “Six Diabetes-Related Vascular Complications – and How to Avoid Them” press release as part of the SVS Diabetes and vascular health, patient outreach campaign.
November, National Diabetes Month, is a great opportunity to draw more attention to the illness for the public, primary care physicians and patients of all ages.
To help out, we have developed:
- A web page of diabetes and vascular disease resources that we hope you will share with patients and colleagues.
- An easy-to-understand infographic that can be printed and posted around the office or in exam rooms.
- The “Six Diabetes-Related Vascular Complications – and How to Avoid Them” press release as part of the SVS Diabetes and vascular health, patient outreach campaign.
November, National Diabetes Month, is a great opportunity to draw more attention to the illness for the public, primary care physicians and patients of all ages.
To help out, we have developed:
- A web page of diabetes and vascular disease resources that we hope you will share with patients and colleagues.
- An easy-to-understand infographic that can be printed and posted around the office or in exam rooms.
- The “Six Diabetes-Related Vascular Complications – and How to Avoid Them” press release as part of the SVS Diabetes and vascular health, patient outreach campaign.
SVS PSO Names New Medical Director
The Society for Vascular Surgery Patient Safety Organization (SVS PSO) welcomes Dr. Jens Eldrup-Jorgensen as its new medical director. He will replace Dr. Jack Cronenwett, who has served as medical director since 2011.
The SVS PSO is a part of the Vascular Quality Initiative (VQI) that also includes 17 regional quality improvement groups and M2S, a commercial technology partner.
The Society for Vascular Surgery Patient Safety Organization (SVS PSO) welcomes Dr. Jens Eldrup-Jorgensen as its new medical director. He will replace Dr. Jack Cronenwett, who has served as medical director since 2011.
The SVS PSO is a part of the Vascular Quality Initiative (VQI) that also includes 17 regional quality improvement groups and M2S, a commercial technology partner.
The Society for Vascular Surgery Patient Safety Organization (SVS PSO) welcomes Dr. Jens Eldrup-Jorgensen as its new medical director. He will replace Dr. Jack Cronenwett, who has served as medical director since 2011.
The SVS PSO is a part of the Vascular Quality Initiative (VQI) that also includes 17 regional quality improvement groups and M2S, a commercial technology partner.
New patient INFO resource available on IBD and pregnancy
AGA has expanded the Patient INFO Center with a new resource that covers the common questions from patients with IBD who are looking to conceive. This easy-to-access and easy-to-read fact sheet covers frequently asked questions from both women and men, and includes information on staying on medications while trying to get pregnant, precautions pregnant women should be aware of, and much more.
The resource guide was written with Sunanda V. Kane, MD, from Mayo Clinic, Rochester, Minn. View, download, print, or share the IBD & Pregnancy FAQ fact sheet with your IBD patients today.
Visit the Patient INFO Center for all patient education on IBD and more.
AGA has expanded the Patient INFO Center with a new resource that covers the common questions from patients with IBD who are looking to conceive. This easy-to-access and easy-to-read fact sheet covers frequently asked questions from both women and men, and includes information on staying on medications while trying to get pregnant, precautions pregnant women should be aware of, and much more.
The resource guide was written with Sunanda V. Kane, MD, from Mayo Clinic, Rochester, Minn. View, download, print, or share the IBD & Pregnancy FAQ fact sheet with your IBD patients today.
Visit the Patient INFO Center for all patient education on IBD and more.
AGA has expanded the Patient INFO Center with a new resource that covers the common questions from patients with IBD who are looking to conceive. This easy-to-access and easy-to-read fact sheet covers frequently asked questions from both women and men, and includes information on staying on medications while trying to get pregnant, precautions pregnant women should be aware of, and much more.
The resource guide was written with Sunanda V. Kane, MD, from Mayo Clinic, Rochester, Minn. View, download, print, or share the IBD & Pregnancy FAQ fact sheet with your IBD patients today.
Visit the Patient INFO Center for all patient education on IBD and more.
From the Editors: Querencia
In the flood of emails, periodicals, Twitter, Facebook, Doximity, Medscape, and other information that washes over surgeons every day, why should they use their precious time to read ACS Surgery News? That question is foremost in the minds of the editors of this publication as we consider news stories and commentaries for inclusion. Is this an article our readers are going to find informative, pertinent, and stimulating? We want ACS Surgery News to be a querencia: a source of reliable, vetted information that gives surgeons a place of intellectual security along the information highway.
The editors of ACS Surgery News understand surgery from the scrub sink up. While our mission includes keeping our readers informed about these looming thunderstorms, we are also privileged to report progress and innovations that keep coming no matter how the forces of red tape and commerce play against our profession. Bringing news of both challenges and beacons of hope for our profession with commentary and perspective from our colleagues is our objective. For the editors, this is both a mission and a pleasure. Since most of the editors and our Editorial Advisory Board (EAB), like our readers, must focus primarily on our jobs as surgeons, teachers, and researchers, we cannot read every journal or attend every meeting. The role of ACS Surgery News is to find the relevant news of interest and importance to surgeons, wherever it may be found, and to report it succinctly and accurately in a readable form. Before an article appears in ACS Surgery News, it is reviewed by the author of the paper or presentation for accuracy and reviewed by the most appropriate member of the EAB as well as by both Co-Editors for importance and relevance to our surgeon readers. We do not want to shy away from controversial topics, but endeavor to present such topics with balance and sensitivity, just as the ACS itself always attempts to do: to shed light, rather than merely heat, on all subjects that we cover in our pages.
The editors of ACS Surgery News hope that in the months and years to come, this publication can be a querencia for the surgeon: a safe and secure place to engage all the forces that a surgeon must confront to be successful. In these pages we hope you will find knowledge, wisdom, camaraderie, and support for your practice, whatever that may be.
Surgery is a life of great joy and great sorrow, sometimes happening all within the same hour. We hope to be part of the joy and to soften the sorrow by being a publication you look forward to reading and wherein you find those things that contribute to your being a great surgeon and human being.
Dr. Deveney is professor of surgery and vice chair of education in the department of surgery, Oregon Health & Science University, Portland. She is the Co-Editor of ACS Surgery News.
Dr. Hughes is clinical professor in the department of surgery and director of medical education at the Kansas University School of Medicine, Salina Campus, and Co-Editor of ACS Surgery News.
In the flood of emails, periodicals, Twitter, Facebook, Doximity, Medscape, and other information that washes over surgeons every day, why should they use their precious time to read ACS Surgery News? That question is foremost in the minds of the editors of this publication as we consider news stories and commentaries for inclusion. Is this an article our readers are going to find informative, pertinent, and stimulating? We want ACS Surgery News to be a querencia: a source of reliable, vetted information that gives surgeons a place of intellectual security along the information highway.
The editors of ACS Surgery News understand surgery from the scrub sink up. While our mission includes keeping our readers informed about these looming thunderstorms, we are also privileged to report progress and innovations that keep coming no matter how the forces of red tape and commerce play against our profession. Bringing news of both challenges and beacons of hope for our profession with commentary and perspective from our colleagues is our objective. For the editors, this is both a mission and a pleasure. Since most of the editors and our Editorial Advisory Board (EAB), like our readers, must focus primarily on our jobs as surgeons, teachers, and researchers, we cannot read every journal or attend every meeting. The role of ACS Surgery News is to find the relevant news of interest and importance to surgeons, wherever it may be found, and to report it succinctly and accurately in a readable form. Before an article appears in ACS Surgery News, it is reviewed by the author of the paper or presentation for accuracy and reviewed by the most appropriate member of the EAB as well as by both Co-Editors for importance and relevance to our surgeon readers. We do not want to shy away from controversial topics, but endeavor to present such topics with balance and sensitivity, just as the ACS itself always attempts to do: to shed light, rather than merely heat, on all subjects that we cover in our pages.
The editors of ACS Surgery News hope that in the months and years to come, this publication can be a querencia for the surgeon: a safe and secure place to engage all the forces that a surgeon must confront to be successful. In these pages we hope you will find knowledge, wisdom, camaraderie, and support for your practice, whatever that may be.
Surgery is a life of great joy and great sorrow, sometimes happening all within the same hour. We hope to be part of the joy and to soften the sorrow by being a publication you look forward to reading and wherein you find those things that contribute to your being a great surgeon and human being.
Dr. Deveney is professor of surgery and vice chair of education in the department of surgery, Oregon Health & Science University, Portland. She is the Co-Editor of ACS Surgery News.
Dr. Hughes is clinical professor in the department of surgery and director of medical education at the Kansas University School of Medicine, Salina Campus, and Co-Editor of ACS Surgery News.
In the flood of emails, periodicals, Twitter, Facebook, Doximity, Medscape, and other information that washes over surgeons every day, why should they use their precious time to read ACS Surgery News? That question is foremost in the minds of the editors of this publication as we consider news stories and commentaries for inclusion. Is this an article our readers are going to find informative, pertinent, and stimulating? We want ACS Surgery News to be a querencia: a source of reliable, vetted information that gives surgeons a place of intellectual security along the information highway.
The editors of ACS Surgery News understand surgery from the scrub sink up. While our mission includes keeping our readers informed about these looming thunderstorms, we are also privileged to report progress and innovations that keep coming no matter how the forces of red tape and commerce play against our profession. Bringing news of both challenges and beacons of hope for our profession with commentary and perspective from our colleagues is our objective. For the editors, this is both a mission and a pleasure. Since most of the editors and our Editorial Advisory Board (EAB), like our readers, must focus primarily on our jobs as surgeons, teachers, and researchers, we cannot read every journal or attend every meeting. The role of ACS Surgery News is to find the relevant news of interest and importance to surgeons, wherever it may be found, and to report it succinctly and accurately in a readable form. Before an article appears in ACS Surgery News, it is reviewed by the author of the paper or presentation for accuracy and reviewed by the most appropriate member of the EAB as well as by both Co-Editors for importance and relevance to our surgeon readers. We do not want to shy away from controversial topics, but endeavor to present such topics with balance and sensitivity, just as the ACS itself always attempts to do: to shed light, rather than merely heat, on all subjects that we cover in our pages.
The editors of ACS Surgery News hope that in the months and years to come, this publication can be a querencia for the surgeon: a safe and secure place to engage all the forces that a surgeon must confront to be successful. In these pages we hope you will find knowledge, wisdom, camaraderie, and support for your practice, whatever that may be.
Surgery is a life of great joy and great sorrow, sometimes happening all within the same hour. We hope to be part of the joy and to soften the sorrow by being a publication you look forward to reading and wherein you find those things that contribute to your being a great surgeon and human being.
Dr. Deveney is professor of surgery and vice chair of education in the department of surgery, Oregon Health & Science University, Portland. She is the Co-Editor of ACS Surgery News.
Dr. Hughes is clinical professor in the department of surgery and director of medical education at the Kansas University School of Medicine, Salina Campus, and Co-Editor of ACS Surgery News.
Contribute to SVS Foundation Annual Campaign
The SVS Foundation’s Annual Report, “Standing on the Shoulders of Giants,” honors innovators and inventors of both the past and the present. Featured are four previous SVS Foundation awardees, plus brief snapshots of SVS giants on whose shoulders today’s members stand.
Read the report here, and please donate to the SVS Foundation’s annual campaign, now underway, to fund the next generation of giants.
The SVS Foundation’s Annual Report, “Standing on the Shoulders of Giants,” honors innovators and inventors of both the past and the present. Featured are four previous SVS Foundation awardees, plus brief snapshots of SVS giants on whose shoulders today’s members stand.
Read the report here, and please donate to the SVS Foundation’s annual campaign, now underway, to fund the next generation of giants.
The SVS Foundation’s Annual Report, “Standing on the Shoulders of Giants,” honors innovators and inventors of both the past and the present. Featured are four previous SVS Foundation awardees, plus brief snapshots of SVS giants on whose shoulders today’s members stand.
Read the report here, and please donate to the SVS Foundation’s annual campaign, now underway, to fund the next generation of giants.
November is National Diabetes Month; SVS Offers Infographic for Members to Give to Patients
November is National Diabetes Month, an opportunity for physicians and surgeons to focus on the disease and its effects. Diabetes is considered one of the largest global health emergencies, dangerous in large part because high blood sugar damages blood vessels, possibly leading to eye disease, heart attacks, PAD, kidney problems and foot ulcers. Diabetes also magnifies the effects of other health complications.
SVS offers members a number of resources on diabetes, including an infographic on how diabetes affects blood vessels in the body. Members may find the infographic useful to download and display, plus print to hand out to patients with diabetes or at risk for the condition.
November is National Diabetes Month, an opportunity for physicians and surgeons to focus on the disease and its effects. Diabetes is considered one of the largest global health emergencies, dangerous in large part because high blood sugar damages blood vessels, possibly leading to eye disease, heart attacks, PAD, kidney problems and foot ulcers. Diabetes also magnifies the effects of other health complications.
SVS offers members a number of resources on diabetes, including an infographic on how diabetes affects blood vessels in the body. Members may find the infographic useful to download and display, plus print to hand out to patients with diabetes or at risk for the condition.
November is National Diabetes Month, an opportunity for physicians and surgeons to focus on the disease and its effects. Diabetes is considered one of the largest global health emergencies, dangerous in large part because high blood sugar damages blood vessels, possibly leading to eye disease, heart attacks, PAD, kidney problems and foot ulcers. Diabetes also magnifies the effects of other health complications.
SVS offers members a number of resources on diabetes, including an infographic on how diabetes affects blood vessels in the body. Members may find the infographic useful to download and display, plus print to hand out to patients with diabetes or at risk for the condition.
Submit Abstracts to VRIC 2017
Abstracts are being accepted through Jan. 18, 2017, for the 2017 Vascular Research Initiatives Conference, to be held May 3, 2017, in Minneapolis.
This one-day meeting emphasizes emerging vascular science and is considered a key event for meeting and reconnecting with vascular research collaborators.
VRIC takes place the day before and in the same venue as the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions.
Abstracts are being accepted through Jan. 18, 2017, for the 2017 Vascular Research Initiatives Conference, to be held May 3, 2017, in Minneapolis.
This one-day meeting emphasizes emerging vascular science and is considered a key event for meeting and reconnecting with vascular research collaborators.
VRIC takes place the day before and in the same venue as the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions.
Abstracts are being accepted through Jan. 18, 2017, for the 2017 Vascular Research Initiatives Conference, to be held May 3, 2017, in Minneapolis.
This one-day meeting emphasizes emerging vascular science and is considered a key event for meeting and reconnecting with vascular research collaborators.
VRIC takes place the day before and in the same venue as the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions.